ÂÜÀòÂÒÂ×

David Clark is a highly experienced medical professional with a focus on clinical development and drug innovation within the biopharmaceutical sector. Currently serving as Chief Medical Officer at Trevi Therapeutics, Inc., since 2022, Clark previously held similar leadership roles at Allena Pharmaceuticals, Aldeyra Therapeutics, Wilson Therapeutics, NormOxys Inc., and TransTech Pharma. Notably, Clark's contributions have advanced therapies targeting chronic cough conditions, rare metabolic disorders, immune-mediated diseases, and more. With a foundational educational background that includes an MD from the University of Edinburgh and MRCP from the Royal College of Physicians in the UK, Clark has developed a robust career encompassing significant clinical roles at Pfizer and SmithKline Beecham, as well as early research in respiratory medicine at the University of Dundee.